AKT1 and acute lymphoblastic leukemia: However, apart from its ability to increase cell proliferation and to exert an anti-apoptotic effect by targeting death-promoting proteins opposed to PI3K (Phosphatidyl-Inositol-3-kinase)/Akt pathway in Acute Lymphoid Leukemia (ALL) [42], the exact mechanism responsible for its oncogenicity remains unknown.